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Abstract
Enterococcus faecalis is a Gram-positive bacterium that normally exists as an intestinal
commensal in humans. Additionally, it can survive in the environment for extended
periods and cause infections in immunocompromised hosts, making E. faecalis a
leading cause of nosocomial infections. Previous work noted that specific fatty acids
found in serum contribute to tolerance of membrane damaging agents, including the
drug daptomycin. However, not all fatty acids found in serum were able to induce such
protection. Herein, we measured a wide array of physiological responses after
supplementation with combinations of protective (i.e., induced daptomycin tolerance)
and non-protective fatty acids. When supplementing cells with either non-protective fatty
acid, palmitic acid or stearic acid, there was a significant increase in generation time
and severely distorted morphology. Both physiological defects were rescued when
these cultures were supplemented with one of the protective fatty acids identified in
serum, oleic acid or linoleic acid. Similarly, membrane fluidity decreased with growth in
either palmitic or stearic acid alone but returned to basal levels when supplemented in
combination with a protective fatty acid. While cell envelope charge has been
associated with tolerance to daptomycin in other Gram-positive bacteria, we concluded
that it does not correlate with the fatty acid induced protection we observed. Further,
daptomycin tolerance could be induced when cultures were supplemented with nonprotective fatty acids in combination with a protective fatty acid. Beyond physiology, we
measured changes in transcription after protective fatty acid supplementation, noting
upregulation in a gene encoding for a glycoside hydrolase as well as the known
daptomycin genetic resistance gene gdpD. Combined, we conclude that a single
protective fatty acid is able to alleviate negative growth defects and protect cells from
daptomycin.
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Chapter I: Introduction
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Enterococci
Enterococcus species are a group of mammalian associated bacteria that persist in
external environments [1]. These species serve as indicators of fecal contamination of
both water systems and meats, but are also responsible for the fermentation of food
products [2]. Both Enterococcus faecalis and Enterococcus faecium are leading causes
of nosocomial infections around the world mainly due to their hardiness and ability to
survive inside and outside of the body for extended periods of time [3]. Enterococci are
considered opportunistic pathogens that live in the intestinal tracts of healthy individuals
and upon niche expansion may cause endocarditis, wound infections and septicemia in
immunocompromised individuals or patients that have received broad antimicrobial
therapy. Enterococci species have both intrinsic and acquired resistance to β-lactams,
fluoroquinolones and glycopeptide antibiotics [4]. Both E. faecalis and E. faecium
possess many antibiotic defense mechanisms, including drug modification, target
modification, and drug efflux pumps, some of which are intrinsic to most isolates [5].
Beyond genetic resistance, E. faecalis has increased tolerance to membrane damaging
agents when grown in host components [1, 6]. More needs to be understood about the
mechanisms used for persistence in external environments as well as resistance and
tolerance to antimicrobial therapies. In this chapter I will explain what is known of the
physiology of E. faecalis that enables it to be a leading worldwide nosocomial pathogen.

Fatty Acid Biosynthesis in E. faecalis
The selectivity of the cell membrane is due in part to the amphipathic nature of the
primary component, phospholipids. The hydrophilic glycerophosphate head interacts
with both the interior cytosol as well as the exterior environment, blocking charged and
large molecules from entering the cell. Fatty acid tails attached to the glycerophosphate
head are hydrophobic, creating a suitable environment for the localization of membrane
proteins via hydrophobic residue interaction. There are two methods E. faecalis
employs to create fatty acids suitable for phospholipid synthesis, de novo fatty acid
biosynthesis and incorporation of exogenous fatty acids.
E. faecalis performs type 2 fatty acid biosynthesis (FASII) (Fig 1.1) to create both
saturated and unsaturated fatty acids from the base molecule acetyl-CoA. Acetyl-CoA
2

carboxyltransferase (AccAD) transfers a carboxyl group to acetyl-CoA, resulting in
malonyl-CoA. The free carboxyl is derived from biotin by biotin carboxylase carrier
protein (AccB) and biotin carboxylase (AccC). The malonyl moiety of malonyl-CoA is
transferred to the acyl carrier protein (ACP) by malonyl CoA-ACP transaclyase (FabD),
making malonyl-ACP. Acyl-ACP and malonyl-ACP are then condensed to form βketoacyl-ACP by β-ketoacyl-ACP synthase III (FabH). This is reduced by 3-OxoacylACP-reductase (FabG) and NADPH producing β-hydroxyacyl-ACP and NADP+. For
saturated fatty acid synthesis, 3-hydroxyacyl-ACP-dehydratase (FabZ) dehydrates βhydroxyacyl-ACP and forms trans-2-enoylacyl-ACP. The final reduction step by enoylACP-reductase (FabI) results in the formation of an acyl-ACP two carbons longer than
the starting molecule. Interestingly, FabI in E. faecalis is similar to FabB in Escherichia
coli [7]. Also note that E. faecalis has both FabI and FabK, an enoyl-ACP- reductase
found in E. coli, present in the genome, but FabK appears non-functional [8]. Elongation
proceeds by the repeated condensation of acyl-ACP or malonyl-ACP with the acyl-ACP
by β-ketoacyl-ACP synthase II (FabF). Elongation generally proceeds until the fatty acid
measures 16 to 18 carbons in length.
Unsaturated fatty acid synthesis differs at the dehydration step of β-hydroxyacylACP. Instead, 3-hydroxyacyl-ACP-dehydratase (FabN) is capable of an isomerization
reaction, resulting in cis-2-enoylacyl-ACP. This molecule is unable to be reduced by
FabI but can be condensed with acyl-ACP or malonyl-ACP by FabF, leading to
elongation and the synthesis of unsaturated fatty acids, acyl chains containing carbon –
carbon double bonds. The mechanism for selection of unsaturated fatty acid synthesis
is currently unknown. However, in E. coli, data can explain how the UFAs may
preferentially be incorporated into lipid headgroup precursors as the temperature
decreases: similar system may exist in E. faecalis. in E. coli, cis-vaccenic acid (C18:1
cis11)

and palmitic acid (C18) compete for the first position in the phospholipid backbone

[9]. At lower temperatures the activity of FabB is increased due to an unknown
mechanism [10]. FabB and FabF are responsible for the elongation of cis-3-decanoylACP into cis-vaccenoyl-ACP, ultimately resulting in cis-vaccenic acid. With a higher
proportion of cis-vaccenic acid to palmitic acid available, cis-vaccenic acid preferentially
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populates the first position of the phospholipid backbone, increasing membrane fluidity
at lower temperatures [9].

Exogenous fatty acid incorporation
Most bacteria are able to transport free fatty acids from the environment into the cell,
which expands the possible carbon sources in a given environment as well as reducing
the cost and time of synthesizing acyl chains for phospholipids. Gram-negative bacteria
such as E. coli use long-chain fatty acid transport protein (FadL) to bind long chain fatty
acids at the outer membrane [11]. Once bound to FadL, acyl-CoA synthetase (FadD)
forms an acyl-CoA using the free fatty acid. The acyl-CoA can be used for β-oxidation or
phosphatidic acid synthesis if the correct acyl chain length is present, generally 14-16
carbons in length but is species dependent [12, 13]. If the environment is rich in
unsaturated fatty acids, E. faecalis could grow without de novo fatty acid synthesis. This
provides an energy advantage if fatty acids chains do not need to be synthesized by the
organism, as well as a protective advantage if oleic acid or linoleic acid are available.
Gram-positive bacteria use a different system that begins with fatty acid binding
protein (FakB), which as the name implies, binds to a free fatty acid and transports it to
the cytosol. There it is phosphorylated by fatty acid kinase (FakA) and ready for
degradation by the β-oxidation pathway or phospholipid synthesis. Bacteria such as B.
subtilis can degrade the fatty acid for energy, but not E. faecalis, therefore I will focus on
incorporation of free fatty acids onto phospholipid head groups. Once phosphorylated
by FakA, two options take place for association onto a head group. The acyl-PO4 can be
used by PlsY for addition onto the sn-1 position of G3P (glyceraldehyde 3-phosphate),
producing lysophosphatidic acid. The second option is for PlsX to create acyl-ACP that
can then be added to the sn-2 position of lysophosphatidic acid, creating phosphatidic
acid.
Interestingly, species belonging to the order Lactobacillale can repress de novo fatty
acid synthesis while using exogenous fatty acids as a source for acyl chains [14]. Work
from multiple groups has shown that the presence of exogenous fatty acids in growth
medium lead to lower amounts of fab transcripts and Acp proteins that are necessary
for de novo fatty acid synthesis in E. faecalis (Saito, unpublished data) [15].
4
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Figure 1.1: Type 2 fatty acid biosynthesis in Enterococcus faecalis.
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A deletion experiment showed that FASII repression is achieved by FabT in
Streptococcus pneumoniae, which binds to DNA and represses transcription of the fab
locus when bound by a long chain acyl chain [16]. A similar phenotype was observed in
E. faecalis after deletion of either fabT or apcB in E. faecalis [15]. Interestingly,
repression by FabT in E. faecalis did not seem as strong as in S. pneumoniae, possibly
necessitating the repeated function of AcpB [15].

Phospholipid Synthesis
Synthesis of phospholipids begins with the formation of the glycerophosphate (G3P)
head group by the reduction of the glycolysis intermediate dihydroxyacetone phosphate
(DHAP) by sn-glycero-3-phosphate synthesis (GpsA). Gram-negative bacteria regulate
GpsA activity by the product, G3P, binding to GpsA. This ensures a steady supply of
G3P for lipid synthesis [13]. Unlike E. coli, Bacillus subtilis lacks tight regulation on
GpsA likely due to amount of G3P required to synthesize the cell wall component
lipoteichoic acid, which contains anywhere from 14 to 33 G3P units [17]. This lack of
regulation is likely present across Gram-positive bacteria, including E. faecalis, for the
same reason as in B. subtilis, but this is not known. E. coli is able to transport G3P into
the cell from the environment via GlpT using a phosphate antiport active transport
system. E. faecalis strain V583 has low protein sequence similarity to a major facilitator
transporter protein NP_814175. This low relation may imply that E. faecalis does not
import G3P, relying on glycerol metabolism to synthesize G3P from dihydroxyacetone
phosphate (Brewer, unpublished observation); however, this remains to be validated
experimentally.
To add the acyl moieties formed by FASII, the cell requires a family of
acyltransferases. Gram-positive organisms use the proteins PlsX, PlsY, and PlsC to
populate both acyl positions, sn-1 and sn-2, of phosphatidic acid. PlsX converts acylACP from FASII to acyl-phosphate (acyl-PO4), which donates its acyl moiety to sn-1 of
G3P via PlsY to generate lysophosphatidic acid. PlsC then populates sn-2 using an acyl
moiety from an acyl-ACP to convert lysophosphatidic acid to phosphatidic acid, a
precursor to most common bacterial phospholipids. For E. faecalis, those include
phosphatidylglycerol (PG), amino modified PG, and cardiolipin (CL).
6

Phosphatidylglycerol
To generate PG from phosphatidic acid, cytidine diphosphate diaglycerol (CDP-DAG) is
synthesized by the addition of cytidine phosphate by phosphatidate cytidylyltransferase
(CdsA) and subsequent elimination of pyrophosphate (Fig 1.2) [18]. PgsA adds glycerol
phosphate to CDP-DAG after to removal of cytidine monophosphate. PG is formed by
the removal of a phosphate by phosphatidylglycerol phosphate phosphatase (PgpP).
PG is the primary phospholipid present in the membrane of E. faecalis and represents
the middle of the road as a two-acyl tailed anionic lipid (Harp, unpublished data). While
plain, PG can be modified to contain a charged amino group or combined into an even
more anionic four-acyl tailed lipid.

Lysyl-Phosphatidylglycerol
Amino-modified PG phospholipids are often found in the membrane of Gram-positive
bacteria, modulating the charge of the cell. The most common amino-PG in E. faecalis
is lysyl-PG (LPG), imbuing a positive charge to the cell. In E. faecalis, peptide
resistance factor 2 (MprF2) catalyzes the lysinylation of PG to form LPG. To date,
conditions have not been described where MprF1 is functional in E, faecalis [19]. After
LPG formation, MprF then moves LPG from the inner leaflet to the outer leaflet by a
flipping mechanism [20]. Increasing cell charge via an MprF gain of function mutation in
S. aureus, only containing one mprf gene, has been implicated in defense from cationic
antimicrobial peptides (CAMPs) via repulsion [21]. Other work has proposed that a large
increase of LPG will protect S. aureus from daptomycin by repulsion [22].

Cardiolipin
CL is a less common phospholipid found in E. faecalis that is simply a combination of
two PG phospholipids, mediated by cardiolipin synthase (Cls). A trio of glycerol
molecules are attached to two diacylphosphatidyl moieties, imparting a unique structure,
aiding in the support of curved cell membrane regions such as septa and poles. A vital
division protein, DivIVA, localizes in microdomains rich in CL, indicating the role of
proper phospholipid localization to proper cell division [23]. Two cls synthase genes
have been identified in E. faecalis [24], but
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Figure 1.2: Phospholipid biosynthesis in Enterococcus faecalis.
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deletion of both leads to mild diminishment of CL in the membrane, implying a yet-to-be
determined additional synthesis mechanism (Harp et al, in preparation).

Membrane Adaptation
The cell envelope, including both the cellular membrane and cell wall, is responsible for
protection of bacteria from environmental damage including temperature, pH,
osmolarity, and so forth. At the same time, the envelope must be flexible in terms of
composition and structure to adapt to the current environment. Specifically, for the
cellular membrane component, a common and simple method of adaptation is to
change the ratio of saturated fatty acids (fatty acids with no carbon to carbon double
bonds) and unsaturated fatty acids (fatty acids with at least one carbon to carbon
double bond). The higher the percentage of saturated fatty acids within a membrane,
the more rigid, and less likely to destabilize at high temperatures [25]. A membrane
dominated by unsaturated fatty acids remains in the liquid-crystalline state at lower
temperatures, allowing vital cell functions to persist [25].
The Gram-positive bacterium Bacillus subtilis uses a lipid desaturase (Des) to
increase membrane fluidity when cold shock is sensed [26]. DesK is a membrane
bound protein that senses membrane fluidity and phosphorylates DesR when the
membrane is too tightly packed [27]. Once DesR is phosphorylated, it transcriptionally
activates des, which then creates a cis bond at the 5th carbon on the acyl tail of
saturated fatty acids [27]. Desaturation of the cell membrane in low temperatures
maintains active transport functioning, and therefore proton dependent ATP generation
continues [26]. In organisms lacking a desaturase mechanism, such as E. coli,
increasing SFA:UFA occurs during biosynthesis, with temperature sensing systems
determining the predominate fatty acid to synthesize [10].

Daptomycin
As noted above, Enterococci species carry resistance mechanisms to a plethora of drug
classes [4]. An increasing prevalence in Vancomycin Resistant Enterococci (VRE),
particularly for E. faecium infections, has caused a corresponding increase in burden
for patients and healthcare systems in European countries [28]. E. faecium is less
prevalent in the Americas, replaced by E. faecalis which is intrinsically resistant to a
9

common drug linezolid thanks to a multitude of drug efflux pumps. Linezolid binds to the
50s ribosomal subunit, halting translation of proteins, showing bacteriostatic activity in
Enterococci infections [29]. Increased resistance to vancomycin and linezolid in the
United States has led to reliance upon daptomycin to treat E. faecalis infections.
Daptomycin is a cyclic lipopeptide effective at treating Gram-positive infections.
The drug was isolated from the soil bacterium Streptomyces roseosporus in the 1980s
and approved for use by the FDA in 2003 [30, 31]. While the exact mechanism is not
known, daptomycin is thought to interact with negatively charged regions of the cell
membrane in a calcium dependent manner and disrupt synthesis of membrane and wall
components [32, 33]. It is one of few Gram-positive targeting antibiotics that is safe for
systemic use. Other common drugs such as vancomycin and linezolid have serious side
effects such as permanent vision or hearing loss.
Genetic resistance to daptomycin is not well understood but has been noted in B.
subtilis, S. aureus, E. faecium, and E. faecalis. There are several mechanisms
proposed for resistance, especially as different genetic markers are associated with the
differing bacterial species. Some theories support a mechanism where a more positive
cellular charge will lead to repulsion of the positively charged daptomycin-calcium
complex [20]. Other proposed mechanisms involved the diversion of the target
phosphatidylglycerol away from division sites, allowing cell reproduction to continue
[20].
Sequencing of a clinical isolate pair before and after daptomycin treatment
revealed multiple genetic alterations arose throughout therapy including mutations in
cardiolipin synthase 1(cls), glycerophosphoryl diester phosphodiesterase (gdpD) and
lipid II interacting antibiotic component (liaF) [34]. As mentioned above, Cls synthesizes
the anionic cardiolipin from two PG molecules and GdpD is a membrane bound protein
thought to assist in glycerol metabolism and phospholipid biosynthesis [34]. Mutations in
cls1 and gdpD both contribute to an altered membrane phospholipid composition. LiaF
is responsible for repressing the membrane bound sensor histidine kinase LiaS, which
phosphorylates the response regulator LiaR. LiaR then activates transcription of
liaIHGFSR [35]. Studies with B. subtilis demonstrated that under normal conditions, LiaI
10

localizes to the membrane and LiaH is present in the cytosol, but during stress LiaH
moves to the membrane with LiaI to perform an unknown function related to cell
membrane homeostasis [36]. Complementation work In E. faecalis revealed that
mutation of liaF increased the MIC of daptomycin, but mutation of gdpD had no effect
on MIC, requiring both mutations for a synergistic effect [34]. Work with cls uncovered
that the mutation in the resistant clinical isolate likely causes an increase in biochemical
activity of the protein, and they speculated a higher percent of cardiolipin in the
membrane, but no experimental evidence has been provided. All of these mutations
must occur for maximum protection from daptomycin, foreshadowing the complicated
effects of daptomycin killing.

Physiological tolerance to daptomycin in E. faecalis
Work by Saito first noted that the growth environment for E. faecalis could induce a
physiological tolerance to daptomycin. Growth in serum or bile induced a daptomycin
tolerant phenotype, but the causative agent was unknown [1]. Further investigation
found the protective components in human fluids are in fact exogenous fatty acids [1].
After supplementation with 15% human serum, they noticed a rise of palmitic acid
(C16:0), stearic acid (C18:0), oleic acid (C18:1 cis9) and linoleic acid (C18:2 cis 9,12) [1].
Further, supplementing a single fatty acid led to the majority of the membrane
compromising of the supplemented fatty acid [1, 6, 37]. While all mentioned fatty acids
were readily incorporated, not all induced protection from daptomycin, introducing the
question of what makes a fatty acid protective [1, 6]. Palmitic acid and stearic acid,
though found in serum and increased in the membrane upon serum supplementation,
did not protect from daptomycin and also introduced growth defects if provided
independently to cultures [1, 6]. Conversely, the fatty acids oleic acid and linoleic acid
provided protection from daptomycin but had no effect on growth [1, 6].
Given that genetic resistance to daptomycin is associated with signaling via
liaFSR, perhaps fatty acids were signaling via this system, leading to the increased
tolerance. Using a mutant strain lacking the stress response regulator liaR, the same
membrane stress assays were performed, challenging cells with daptomycin after
supplementation with fatty acids found in human serum [37]. When challenged with
11

daptomycin, ∆liaR strain showed increased survival when supplemented with a
protective fatty acid [37]. This provides evidence for a tolerant mechanism separate
from the stress response system LiaIHGFSR.
Further work by Harp investigated the roles of phospholipid synthesis proteins
Cls and MprF2, responsible for production of cardiolipin and Lysyl-PG respectively.
Interestingly, protective fatty acids are still able to increase daptomycin tolerance in
mutants lacking MprF2 (Harp, Unpublished). Lysyl-PG was undetectable in the
membrane of ∆mprF2 cells, confirming that a simple charge repulsion is not responsible
for the daptomycin tolerant phenotype (Harp, Unpublished data). A recently
hypothesized model claims that cardiolipin prevents daptomycin from flipping into the
inner leaflet and acts as a poor target for daptomycin [32]. Supporting data for this
hypothesis includes daptomycin challenge of a mutant lacking cls2 and cls1 leading to
lower basal survival than wild type cells (Harp, Unpublished data). After protective fatty
acid supplementation, like with all other tested mutants, there was increased survival
from daptomycin challenge (Harp, Unpublished). Once again it was shown that the
daptomycin tolerant phenotype is not related to any known genetic resistance
mechanisms in E. faecalis or closely related bacteria.
Given the lack of congruency between genetic mutations in clinical resistance
and the induction of physiological tolerance by eukaryotic fatty acids, perhaps altered
biophysical properties are responsible for this tolerance. It has already been shown up
to this point that saturated fatty acids found in the membrane do not provide protection
from daptomycin, and if supplemented alone will cause growth defects [6]. Growth
defects range from longer generation time and growth stasis to deformed cell
morphology at the individual cell level [1, 6]. Unsaturated fatty acids oleic acid and
linoleic acid have little to no effect on growth and provide multiple logs of improved
survival after challenge with daptomycin [1, 6]. Single fatty acid supplementation
dominates the membrane composition as determined by gas chromatography of fatty
acid methyl esters (GC-FAME) [1]. This data paired with observations of lowered fab
transcription indicate that the supplied fatty acids are being incorporated into the cell
membrane either as free fatty acids or phospholipids (Saito, Unpublished).
12

Research addressed in this work
Given the abundance of data showing the physiological effects that single fatty acids
have on E. faecalis, we find it curious that a combination such as human serum, which
contains fatty acids that are protective from daptomycin as well as deleterious to cell
health, have no negative consequences. Chapter II is dedicated to characterizing the
physiological effects of various fatty acid combinations, containing both protective and
non-protective fatty acids. After all the mentioned past work, it was clear that the
observed tolerance was induced by fatty acids, but it is not known if oleic acid and
linoleic acid cause changes in membrane physiology or induce a transcriptional change.
In chapter III I attempt to use transcriptomics in an effort to better understand the
reaction of the cell leading to a daptomycin tolerant phenotype.
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Abstract
Enterococcus faecalis is a Gram-positive bacterium that normally exists as an intestinal
commensal in humans. Additionally, it can survive in the environment for extended
periods and cause infections in immunocompromised hosts, making E. faecalis a
leading cause of nosocomial infections. Previous work noted that specific fatty acids
found in serum contribute to tolerance of membrane damaging agents, including the
drug daptomycin. However, not all fatty acids found in serum were able to induce such
protection. Herein, we measured a wide array of physiological responses after
supplementation with combinations of protective (i.e., induced daptomycin tolerance)
and non-protective fatty acids. When supplementing cells with either non-protective fatty
acid, palmitic acid or stearic acid, there was a significant increase in generation time
and severely distorted morphology. Both physiological defects were rescued when
these cultures were supplemented with one of the protective fatty acids identified in
serum, oleic acid or linoleic acid. Similarly, membrane fluidity decreased with growth in
either palmitic or stearic acid alone but returned to basal levels when supplemented in
combination with a protective fatty acid. While cell envelope charge has been
associated with tolerance to daptomycin in other Gram-positive bacteria, we concluded
that it does not correlate with the fatty acid induced protection we observed. Further,
daptomycin tolerance could be induced when cultures were supplemented with nonprotective fatty acids in combination with a protective fatty acid. Combined, we conclude
that a single protective fatty acid is able to alleviate negative growth defects and protect
cells from daptomycin.

Importance
With an increasing prevalence of antibiotic resistance in the clinic, we strive to
understand more about microbial defensive mechanisms. An interesting tolerance
physiology was discovered in Enterococcus faecalis that is not genetic in nature, but
regardless results in the increased survival of bacterial populations after treatment with
the antibiotic daptomycin. This unknown tolerance mechanism likely synergizes with
antibiotic resistance in the clinic. Given the tolerance phenotype is induced by
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incorporation of fatty acids present in the host, it can be assumed that all infections by
this organism require a higher dose of antibiotic. The mixture of fatty acids in human
fluids is quite diverse, with little understanding how combinations of fatty acids interplay
with the tolerance phenotype we observe. It is crucial to understand the effects of fatty
acid combinations on E. faecalis physiology if we are to suppress the tolerance
physiology in the clinic.

Introduction
Enterococcus faecalis is a Gram-positive bacterium known primarily as a commensal in
the mammalian intestine. In immunocompromised individuals, however, it can cause a
variety of complications if it colonizes outside the intestine: these include surgical wound
and urinary tract infections, endocarditis, and bacteremia. E. faecalis is also resilient to
a variety of stressors allowing it to survive outside the body for extended periods of time
which likely increases transfer to patients in the hospital setting [1]. Along with being
resilient to environmental stressors such as heat, acid, and osmotic shock [2], E.
faecalis is resistant to different classes of antibiotics, complicating treatment strategies
[3].
To combat drug resistant enterococcal infections, clinicians have utilized the
antibiotic daptomycin. This drug is thought to insert into phosphatidylglycerol portions of
the cell membrane in a calcium dependent manner leading to ion leakage and cell death
[4]. Despite its success, clinical resistance to daptomycin occurs for enterococcal
infections [5]. Further, studies have also shown that the growth environment of E.
faecalis can induce a physiological tolerance to this antibiotic. Specifically, growth in the
presence of bile or serum, mimicking its lifestyle as a commensal and pathogen
respectively, led to protection from daptomycin, and this tolerance was induced by
specific fatty acids found within bile or serum [6]. This priming also protected E. faecalis
from high concentrations of human bile and sodium dodecyl sulfate (SDS),
demonstrating that protection was not specific to daptomycin. Further, this protection
was not due to the selection of genetic mutants but rather due to altered cellular
physiology [6, 7]
Fatty acid analysis of E. faecalis cells after serum supplementation showed an
increase in oleic acid (C18:1 cis9), linoleic acid (C18:2 cis-9,12), palmitic acid (C16:0), and
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stearic acid (C18:0) [6, 8]. The increase in these four species led to a decreased
proportion of other native fatty acids, most notably cis-vaccenic acid (C18:1 cis11). Further
analysis showed that supplementation only with oleic acid or linoleic acid provided
protection from membrane stress agents [6, 9]. Despite stearic acid and palmitic acid
being produced and found natively in the membrane of E. faecalis, supplying either one
exogenously did not induce tolerance [6, 9].
Not only do stearic acid and palmitic acid fail to induce daptomycin tolerance,
they also caused considerable defects to cellular physiology when supplemented
exogenously to cultures [6, 9]. Specifically, generation time was increased significantly
from control cultures, and the morphology of these cells was greatly perturbed.
Importantly though, protection and physiology were found not to be exclusive of one
another, as the addition of linoleic acid to cultures induced daptomycin tolerance and
also increased generation time [6, 9]. Based on the observed differences in daptomycin
induced protection of each fatty acid, we chose to define any exogenously supplied fatty
acid that induces daptomycin tolerance as a protective fatty acid, and all other fatty
acids as non-protective fatty acids.
It is interesting to note that human serum is effective at conferring daptomycin
tolerance to E. faecalis while containing the non-protective fatty acids stearic and
palmitic acid that can cause severe physiological defects [6, 8]. We hypothesized that
the eukaryotic fatty acids oleic acid and linoleic acid drive a membrane protective
response even in the presence of non-protective fatty acids. Within this work we show
the supplementation of protective and non-protective fatty acids in combination induce
tolerance from daptomycin in E. faecalis without observable negative physiological
effects.

Materials and Methods
Bacterial Growth Conditions. E. faecalis OG1RF was grown statically at 37°C in brain
heart infusion (BHI) for all experimental conditions. Overnight cultures were diluted to
OD600nm 0.01 before experimentation. For long-term supplementation, fatty acids were
added at the time of dilution. For short-term supplementation, fatty acids were added to
cultures during exponential phase, OD600nm 0.25 [9]. Unless otherwise noted, cells were
harvested at OD600nm 0.3 for long-term supplementation and 30 minutes after fatty acid
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addition for short-term supplementation. Growth was monitored by OD600 and all fatty
acids (Sigma) were supplemented to a final concentration of 5 µg ml-1: oleic acid (C18:1
cis9)(17.7µM),

linoleic acid (C18:2 cis-9,12) (17.82 µM), palmitic acid (C16:0) (19.49 µM), and

stearic acid (C18:0) (17.58 µM). Human serum (MP biomedicals) was supplemented at a
final concentration of 15%.
Gas Chromatography of Fatty Acid Methyl Esters (GC-FAME). Cells were grown
using both long-term and short-term supplementation methods described above.
Cultures (15mls) were harvested at 2739g for 10 minutes, washed extensively in 1x
phosphate buffered saline (PBS) twice, pelleted and stored at -80°C. GC-FAME was
performed by Microbial ID (Newark, DE) using methods described previously [10].
Scanning electron microscopy. Bacterial cultures (25mls) were grown using the longterm supplementation methods described above. The cells were harvested at 2739g for
10 minutes, washed in 1x PBS and resuspended in 500 µl 3% glutaraldehyde for one
hour in order to fix the cells. Cells were washed three times in 10 mls sterile water,
decanted and resuspended in the remaining water. An aliquot (20µl) of each sample
was fixed to a 5 x 5 mm silicon chip with poly-lysine then dehydrated using a series of
ethanol washes (25, 50, 70, 95, and 100%) for ten minutes each. After ethanol washes,
the cells were placed in a LADD critical point dryer for three cycles of 10 minutes. The
dried samples were then coated with iridium using a sputter coater and visualized using
a Zeiss Auriga 40 at the Center for Advanced Microscopy and Imaging at the University
of Tennessee at a kEV of 5.0. Biological duplicates were performed for each growth
condition and a minimum of 10 fields were imaged for each sample.
Determination of cellular charge. The overall charge of the bacterial cells was
determined using a previously described method [11] with modifications. Bacterial
cultures were grown using the short-term supplementation methods described above.
Cells were washed twice with PBS and resuspended to a final OD600nm of 3.0 in 3.0 mL
20mM 3-(N-morpholino)propanesulfonic acid (MOPS) with 1 mg ml-1 cytochrome C and
incubated at room temperature for 10 minutes. The samples were centrifuged at 2739g
for 10 minutes, the supernatant was extracted and measured at OD530nm. The
concentration of cytochrome C measured was based on a standard curve of known
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cytochrome C concentrations, and the percent unbound cytochrome C was calculated
for n=3 biological replicates. A higher percentage of unbound cytochrome C represents
a more positively charged population of cells.
Protoplast generation. Protoplast generation was based on [12] with modifications.
Cultures of OG1RF (10ml) were grown as described above for short-term
supplementation conditions. Cultures were harvested via centrifugation (2739g),
washed with 1x PBS and resuspended in half (5mls) the original volume with isotonic
buffer (20% sucrose, 0.145M NaCl, 50mM Tris-HCl). Samples were incubated with 1
mg ml-1 lysozyme for 60 minutes at 37°C. Removal of cell wall was verified by Gram
staining.
Anisotropy. Protoplasts were generated using the method above. Protoplasts in
isotonic solution were incubated with 2nM 1,6 diphenyl 1,3,5 hexatriene (DPH) at 37°C
for 30 minutes. An Agilent Technologies Cary Eclipse fluorescent spectrophotometer
was used to measure the r value with an excitation wavelength of 350 nm emission
wavelength of 428 nm. The observed biological range of values for anisotropy using
DPH is 01. to 0.3 with a lower number meaning the membrane is more fluid [13].
Cerulenin Rescue assay. Cells were grown as described above and diluted back into
medium containing cerulenin at 5 μg ml−1 and either ethanol at 0.1% final concentration
or the indicated fatty acid(s) at 5 μg ml−1. As a control, cells were also diluted back into
medium lacking the inhibitor or fatty acids and indicated as no treatment.
Daptomycin challenge assay. Cultures were grown and harvested using short-term
supplementation described above, with the exception of those grown in the presence of
serum, which was via the long-term supplementation method. Immediately after
harvest, cells were spun at 2,739 g, decanted, and washed with 1x phosphate buffer
solution (PBS) twice. Cells were resuspended in an equivalent volume BHI with 10 mM
calcium chloride. Cultures were then treated with 30 µg ml-1 of daptomycin. After
addition of daptomycin, cells were incubated at 37°C; aliquots were removed at 15, 30,
and 60 minutes and serially diluted using 0.9% sodium chloride (NaCl). The dilution
series was plated on BHI agar plates, grown for 16-20 hours at 37°C, and colony
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forming units were enumerated. The log number of survivors was plotted against time
for n=3 biological replicates.

Results
Protective fatty acids rescue E. faecalis growth from non-protective fatty acids.
Previous work has shown that the addition of single fatty acids to E. faecalis OG1RF
cultures can impact cellular growth, morphology and induce daptomycin tolerance [6, 9].
However, these effects were dependent solely on the fatty acid supplied. If supplied
independently, both palmitic acid (C16:0) and stearic acid (C18:0) caused an increase in
generation time, led to altered cell morphology, and neither could induce tolerance to
daptomycin. Yet, these two fatty acids are found at increased levels in cellular
membranes when supplemented with either bile or serum, and growth in bile and serum
can induce daptomycin tolerance. On the contrary, oleic acid (C18:1 cis 9) and linoleic acid
(C18:2 cis9,12) are also found in bile, serum, and can induce daptomycin tolerance
independently. We wanted to examine if the negative consequences of exogenously
supplied palmitic or stearic acid on the physiology of OG1RF would be alleviated if oleic
acid or linoleic acid were also provided.
Palmitic acid supplementation alone caused an early stasis period (Fig. 2.1) and only
reached stationary phase after selection of a suppressor mutant population [4, 7].
However, supplementation with either oleic acid or linoleic acid prevented this early
stasis and growth resembled that of solvent control cultures (Fig. 2.1). Given how well
the additional oleic acid or linoleic could ameliorate the negative consequences of
palmitic acid on growth, we investigated whether oleic acid could restore growth to
cultures that entered a palmitic acid-induced stasis. We supplied palmitic acid at
dilution, and once stasis was established, oleic acid was added. By supplementing oleic
acid as late as 90 minutes post-stasis, the culture was able to resume growth, (Fig. 2.1).
Re-dilution of these rescued cells indicated that oleic acid did not select for a genetic
mutant isolate, as these cells were unable to grow in the presence of palmitic acid when
challenged again.
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Figure 2.1: Growth of OG1RF in fatty acid mixtures. Addition of a protective fatty
acid relieves growth defects of either palmitic acid (C16:0) or stearic acid (C18:0) on
OG1RF. All fatty acids were added as a final concentration of 5 µg ml-1, ethanol
(solvent control) was added at an equal volume. (A) Addition of Oleic acid (C18:1 cis 9);
(B) addition of linoleic acid (C18:2 cis 9, 12). (C) Addition of SLOP, mixture stearic acid,
palmitic acid, oleic acid, and linoleic acid). (D) Palmitic acid was added at the time of
dilution: stasis indicated by the black arrow. Oleic acid addition (indicated in arrows) at
30, 60, and 90 min post stasis. N=3 for all experiments.
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Supplementation with stearic acid, while not as severe in terms of growth effects
as palmitic acid, increased generation time of OG1RF (Table 2.1). However,
supplementation with linoleic acid mixture restored growth kinetics to that of control
cultures (Fig. 2.1, Table 2.1). Supplementation with oleic acid mixtures lowered the
generation time from the non-protective fatty acid alone but did not completely restore to
control levels (Fig. 2.1, Table 2.1). Generation time of palmitic acid supplemented cells
is not calculable due to early stasis, but combination supplementation with palmitic acid
and a protective fatty acid prevents that stasis (Figure 2.1).
As noted, OG1RF cultures supplemented with serum have increased amounts of
stearic, linoleic, oleic, and palmitic acids in their membranes [6, 8]. To mimic this, we
simulated this membrane profile by adding a mixture containing 5 µg ml-1 each of these
fatty acids to the culture (referred to as SLOP: stearic acid, linoleic acid, oleic acid, and
palmitic acid). This mixture, however, had no obvious impacts on growth dynamics as
cultures supplemented with SLOP resembled that of solvent control (Fig. 2.1C, Table
2.1). These different growth conditions indicate that the presence of a protective fatty
acid is sufficient to rescue cultures from the negative growth effects caused by nonprotective fatty acids.
Supplementation with unsaturated fatty acids has been previously shown to
rescue cells from fatty acid biosynthesis inhibition by cerulenin [6]. To see if fatty acids
mixtures could rescue from cerulenin, we supplemented cultures with single fatty acids
and combinations. Similar to their effects on growth, fatty acid mixtures predominantly
induce physiological responses like a protective fatty acid alone. Both oleic acid and
linoleic acid rescue growth of OG1RF from cerulenin as a single fatty acid supplement
and in combination with a non-protective fatty acid (Figure 2.3). Oleic acid combinations
mimic the rescue seen by oleic acid alone, greatly increasing growth from solvent
control and saturated fatty acid supplementation (P value <0.001). Further, linoleic acid
combinations are similar to linoleic acid alone, rescuing from cerulenin unlike solvent
control and saturated fatty acid supplements (P value <0.001). This indicates that fatty
acid synthesis inhibition is bypassed by incorporating unsaturated exogenous fatty
acids.
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Protective fatty acids prevent negative morphological effects from saturated fatty
acids. It was previously noted that addition of palmitic acid and stearic acid caused
severe distortion to cellular morphology, despite their presence in bile and serum [6, 9].
Given the ability of oleic acid and linoleic acid to suppress negative growth effects, we
hypothesized that their addition would also help restore morphology of OG1RF cells
grown in either palmitic or stearic acids to that of control cultures.
We found that the protective fatty acids induced a truncated morphology (Fig.
S2.1), but otherwise the morphology resembled that of control cultures, as noted
previously. Cells supplemented with palmitic acid were severely distorted in their shape,
oftentimes with little or no distinction from one cell to the next. Unlike the characteristic
diplococci shape, we observed what appeared to be curved cells branching off from
non-polar ends (Fig 2.3). Cells supplemented with palmitic acid in conjunction with oleic
acid or linoleic acid however, had a morphology like control cells, with apparent normal
septum placement.
Stearic acid supplementation also led to apparent misplacement of septa and
improper cellular division, similar to palmitic acid supplemented cells. The cells also
appeared “wrinkled” which may be due to cell wall defects (see discussion). However,
when given in combination with oleic or linoleic acids, cellular morphology is restored to
that of control cells.
Given these results and the above-mentioned growth kinetics, it was not
surprising to note that cells supplemented with the mixture SLOP also had a
morphology that resembled control cultures. Combined, the addition of either oleic or
linoleic acids can prevent negative cellular morphology associated with supplementation
of the saturated, non-protective fatty acids palmitic and stearic acid.
Fatty acid supplementation causes a varied response to cell envelope charge. In
Staphylococcus aureus, an increase in positively charged lysl-phosphatidylglyecerol
(LPG) has been associated with a reduction in ion leakage caused by cationic
antimicrobial peptides[14]. A study with Bacillus subtilis noted than increase in positively
charged LPG or a decrease in anionic phosphatidylglycerol (PG) led to increased
resistance to daptomycin [15]. Given the morphological alterations noted above, we
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Table 2.1 Generation time of OG1RF in BHI and fatty acid supplements.

Medium Constituent

Generation Time (minutes)

Ethanola

39.69 ± 0.54

C18:1 cis9b

34.91 ± 1.03

C18:2 cis-9,12b

37.07 ± 0.97

C16:0b

N/A

C18:0b

69.34 ± 3.41

C18:1 cis9 C16:0c

43.35 ± 0.67

C18:1 cis9 C18:0c

43.61 ± 0.85

C18:2 cis-9,12 C16:0c

40.17 ± 0.51

C18:2 cis-9,12 C18:0c

39.34 ± 0.84

SLOPc

37.87 ± 1.05

Human Serumd

41.32 ± 0.97

aEthanol
bSingle

solvent control was added to a final concentration of 0.2%

fatty acid supplemented to a final concentration of 5 µg ml-1

cCombination
dHuman

of fatty acids supplemented to a final concentration of 5 µg ml -1 each

serum supplemented to a final concentration of 15%
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Figure 2.2: Cerulenin challenge of OG1RF. OG1RF supplemented with indicated fatty
acid(s) and 5 µg ml-1 cerulenin. A) shows oleic acid combinations and B) shows linoleic
acid combinations. n=3.
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Figure 2.3: Scanning electron microscopy of OG1RF in mixed fatty acid
supplements. Images of OG1RF in exponential phase after long-term supplementation
with 5µg ml-1 fatty acids. Images taken at 45,000 magnification at KeV 5.0. Scale bar
represents 0.5 µm. Sample image of n=2 biological replicates with 10 fields examined
per replicate.
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hypothesized that there may be overall changes to cellular envelope charges that were
influencing cellular physiology and daptomycin protection/tolerance. Thus, we choose
to measure overall cell envelope charge via interactions with the positively charged
protein cytochrome C using previously described methods with modifications [11].
Surprisingly, not all conditions impacted cellular charge in comparison to control
cultures (Fig 2.4). Addition of oleic acid, which is protective, caused no change, while
linoleic acid caused a significant decrease in cell charge (P value < 0.005). Linoleic acid
combinations are significantly different from linoleic acid alone (P value < 0.0001),
contrary to previous trends. Both serum and SLOP supplementation caused a modest
but significant increase in cell charge (P values < 0.005 and 0.0001 respectively).
Palmitic acid, but not stearic acid alone, supplementation led to a significant increase in
surface charge (P value < 0.0001). Thus, while cell charge did vary with fatty acid
supplement, there was no obvious correlation between overall cell charge and
protection from daptomycin.
Non-protective fatty acids alter membrane fluidity. The nature of the cellular
membrane is to be flexible dependent upon the environment, altering membrane fluidity
to maintain both a protective barrier and functioning membrane proteins. Fatty acid
supplementation caused a significant change in proportion of fatty acid species
incorporated in the membrane as reported previously [6, 9] These changes, particularly
those that impact the ratio of saturated to unsaturated fatty acids, should also impact
membrane fluidity, altering the ability of molecules to interact, which may impact the
effectiveness of daptomycin [16]. We performed anisotropy using the dye DPH to
determine membrane fluidity on protoplasts to ensure proper interaction of the dye with
the cellular membrane.
Cells supplemented solely with the non-protective fatty acid palmitic or stearic
acid gave a statistically significant higher r value, indicative of a more rigid membrane
than control (Fig 2.5). Both stearic acid and palmitic acid supplemented cells were
significantly different from all other conditions. This correlated well with the previously
reported saturated: unsaturated fatty acid ratio of such cells [6]. However,
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Figure 2.4: Cell charge of OG1RF after mixed fatty acid supplementation.
Alterations in cell envelope charge upon supplementation. Interaction of positively
charged cytochrome C with OG1RF cells; y axis indicates a more positive cell charge.
For all cases, cells supplemented with 5 ug ml-1 each fatty acid, 15% human serum, or
equivalent volume of ethanol (solvent control) until exponential phase. A) Oleic acid
(C18:1cis9) combinations, B) linoleic acid (C18:2cis9, 12) mixtures and C) human serum and
SLOP. For all samples, n=3. Letter (A, B or C) above bar denotes groups of
significance, with different letters representing a significant difference between groups,
P<0.05.
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supplementation with either oleic acid or linoleic acid did not alter fluidity from that of
control cells. Combining the fatty acids, we noted that membrane fluidity returned to
that of control cultures. Thus, while saturated fatty acids rigidify the overall membrane,
growth with protective fatty acids appear to have no impacts (see discussion).
Protection from daptomycin by beneficial fatty acid supplements is not
hindered by the presence of toxic fatty acids. Thus far our data is supportive of
protective fatty acids driving cellular physiology when given with non-protective fatty
acids. We hypothesized that protection from daptomycin by the fatty acid mixtures
serum and/or bile is thus likely driven by oleic or linoleic acids despite the presence of
non-protective fatty acids. Therefore, we examined the induction of daptomycin
tolerance by our mixtures as previously described [9].
As noted previously, the addition of supplementation with either oleic acid or
linoleic acid led to a 2-log increase in survival after daptomycin treatment compared to
the solvent control (Fig 2.6). This was in contrast to supplementation with either palmitic
acid or stearic acid, which had similar survival to the solvent control. However, addition
of oleic acid to either palmitic acid or stearic acid resulted in increased survivors over
solvent control, similar to protection by oleic acid alone. Supplementation with linoleic
acid or a linoleic acid combination also led to a significant increase in survivors.
However, protection induced by human serum was significantly greater than control,
non-protective fatty acids, oleic acid, and oleic acid combination supplemented cells.
The protection provided by SLOP was 4-fold over control and significantly better than all
supplements except human serum. These findings reinforce the conclusion that host
derived fatty acids are sufficient to provide protection from daptomycin. This data also
indicates that a single protective fatty acid is both necessary and sufficient for increased
survival when challenged with daptomycin in the presence of a non-protective fatty acid.
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Figure 2.5: Membrane fluidity of OG1RF after short term fatty acid
supplementation. Anisotropy was determined using DPH with excitation wavelength
350nm and emission wavelength 428nm. n=3. Asterisks indicate significance from
ethanol (solvent control) as follows: **** P-value < 0.0001.
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Figure 2.6: Daptomycin challenge of OG1RF after fatty acid mixture
supplementation. Oleic or linoleic acid can induce daptomycin protection in the
presence of non-protective fatty acids. Membrane challenge by 30 µg ml-1daptomycin
after short term supplementation with fatty acids. (A) Supplementation with oleic acid
(C18:1 cis9) or mixtures containing oleic acid led to an increase in survivors for all time
points (P < 0.0001). Cultures supplemented with oleic acid did not differ from cultures
supplemented with oleic acid mixtures. (B) Supplementation with linoleic acid (C18:2 cis9,12)

or mixtures containing linoleic acid also led to an increase in survivors at all time

points (P < 0.0001). Cultures supplemented with linoleic acid did not differ from cultures
supplemented with linoleic acid mixtures. (C) Supplementation with either human serum
(15%) or SLOP led to an increase in survivors at all time points (P < 0.0001).
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Discussion
Previously, we had noted that growth of E. faecalis in either serum or bile resulted in
increased proportions of palmitic acid (C16), stearic acid (C18), oleic acid (C18:1 cis9) and
linoleic acid (C18:2 cis9,12) and protection from daptomycin [6, 9]. However,
supplementation with individual fatty acids resulted in two distinctive phenotypes:
daptomycin protective versus non-protective. In this study, we examined the effects of
these specific fatty acid mixtures on the physiology of E. faecalis. We found that a
combination containing at least one protective fatty acid will induce protection from
daptomycin and can prevent negative physiological effects that are observed after
supplementing with a saturated, non-protective fatty acid. In particular, we noted that
membrane fluidity was restored to control culture levels, which may be driving the
overall improved health of these mixture cells. Changes in cellular charge did not
correlate with restored cellular health and daptomycin tolerance, indicating that this
feature may not be the main driver in E. faecalis for fatty-acid induced tolerance.
A major consequence we noted from supplementing cells with either palmitic acid
or stearic acid was severe morphological deformities (Fig 2.3). Cells appeared with
altered placement of septa and clear problems with proper cellular division. This
morphology is reminiscent of E. faecalis with non-functioning DivIVA, which localizes to
cell poles and septa to mediate proper cell division [17]. We clearly observe defective
reproduction in cells supplemented with saturated fatty acids, possibly due to improper
localization of DivIVA and consequently aberrant peptidoglycan synthesis [17]. As
shown with growth, defective cell morphology is rescued by addition of either protective
fatty acid, suggestive that these unsaturated fatty acids may help restore proper
membrane protein localization and/or function
A recent investigation into the mechanism of daptomycin killing revealed that
membrane fluid microdomains of Bacillus subtilis are disrupted, leading to delocalization
of membrane associated machinery vital for cell division. [14]. Daptomycin is thought to
decrease fluidity after insertion, so a more fluid membrane is theoretically less sensitive
to the membrane disrupting effects of this proposed mechanism. While we do not
observe increased fluidity after protective fatty acid supplementation, it is entirely
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possible that we have encountered a technical lower limit while using fluorescent
anisotropy. Another possibility is that membrane proteins compensate for the increased
phospholipid fluidity. Regardless, more work must be done on interactions between
daptomycin and cell membrane fluid microdomains.
Other work has implied that daptomycin is susceptible to repulsion by positively
charged cell envelopes and does not interact to form appropriate pores [14, 18]; our
own observations (data not shown) suggest that growth supplementation can lead to an
increase in lysl-phosphatidylglycerol (LPG) in cellular membranes, which would have an
overall impact of reducing the negative charge of enterococcal cellular envelope.
Mutants lacking MprF2 have greatly reduced LPG in the membrane and are more
susceptible to cationic antimicrobial peptides (CAMPs) [19]. In the closely related
organism, Staphylococcus aureus, the dlt operon is responsible for the D-alanylation of
lipoteichoic acid, resulting in an increased cell wall charge. Upregulation of the dlt
operon in S. aureus has been associated with tolerance to daptomycin [20]. However,
under our conditions, there does not seem to be a correlation in overall cell charge and
protection from daptomycin. Indeed, the highest cell charge, which would theoretically
lead to greater tolerance to daptomycin, is induced by palmitic acid supplementation.
Protective fatty acid supplementation caused a variety of cell charges, ranging from
higher to lower than the solvent control. These data combined lead us to conclude that
daptomycin repulsion is likely not how fatty acid supplementation induce protection.
As shown previously [6], growth in saturated fatty acids severely alters saturated:
unsaturated fatty acids in the cell membrane. This alteration would likely lead to a more
rigid membrane, and perhaps exacerbate the effects of daptomycin. Given the target
and proposed mechanism of daptomycin, it is likely that the correlation observed
between membrane fluidity and protection strongly indicates how exogenous fatty acids
provide tolerance to the drug. To investigate this hypothesis, we looked at overall
membrane fluidity using the fluorescent lipid dye DPH on OG1RF protoplasts. While we
do see a reduction in membrane fluidity after supplementation with non-protective fatty
acids, fluidity is not increased from solvent control after supplementation with protective
fatty acids or protective mixtures. It should be noted that this method does not
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distinguish lipid microdomains, but rather measures the overall or average membrane
fluidity; regardless, the decreased overall fluidity observed may be influencing the
proper interaction of daptomycin with the cellular membrane.
Herein we showed that oleic acid and linoleic acid are able to rescue from the
negative physiological effects of non-protective fatty acids, but the exact mechanism by
which they induce daptomycin tolerance is still unclear. Our combination of host
derived, exogenous fatty acids induced the same protection as human serum, indicating
that not only are protective fatty acids capable of inducing daptomycin tolerance in the
presence of non-protective fatty acids, but oleic acid and linoleic acid are solely
responsible for providing the protection observed after supplementation with human
serum. In conclusion, we have described physiological effects that are restored by
protective fatty acid combination supplementation and demonstrated that protective fatty
acids induce tolerance to daptomycin in the presence of non-protective fatty acids.
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Figure 2.7: Large field view of OG1RF via scanning electron microscopy. Scanning
Electron Microscopy of Enterococcus faecalis after long-term supplementation with fatty
acids. Images taken at 10,000 magnification at KeV 5.0. Scale bar represents 1 micron.
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Figure 2.8: Average cell length of OG1RF after mixed fatty acid supplementation.
Average cell length of 30 individuals per condition. Palmitic acid (C16) does not induce
change in cell length from solvent control. All other conditions shorten the cell length.
High standard error is attributed to varying stages of reproduction that was captured for
each sample.
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Introduction
Enterococcus faecalis is a Gram-positive facultative anaerobe primarily existing as a
commensal in mammalian intestines. Given this, enterococci species are used as
indicators of fecal contamination, and in some cases, key organisms for the
fermentation of specific food products [1]. In immunocompromised individuals, however,
uncontrolled bacterial growth leads to diseases such as septicemia and endocarditis [2].
Surgical wounds also act as a point of entry for E. faecalis, causing infections that are
difficult to eradicate. E. faecalis is also resilient to a variety of environmental stressors,
increasing the time it can survive outside of a mammalian host [3]. Along with being
resilient to environmental stress, E. faecalis is resistant to different classes of
antibiotics, complicating treatment strategies.
Multiple antibiotics are currently in use to treat enterococcus infections, including
vancomycin, linezolid, and daptomycin. Vancomycin is a glycopeptide often used for
intestinal Clostridium difficile or systemic Gram-positive infections. It acts by binding to
the D-ala D-ala residues that are the binding substrates for peptidoglycan cross-linking
by Penicillin binding protein (PBP). PBP cross-links the D-ala D-ala residues of
peptides, securing glycan molecules together forming a complete peptidoglycan wall.
When PBP is outcompeted by vancomycin, the wall is not formed and cell division
results in a spheroplast that is incredibly sensitive to environmental damage. The
discovery of vancomycin resistant enterococci in the 1980’s led to a search for other
drugs effective against Gram-positive bacteria. In 2000, linezolid was approved for
clinical use for short durations as long term can lead to nerve damage and permanent
vision loss. Linezolid is an oxazolidinone drug that binds to the 50s ribosomal subunit,
halting protein synthesis at the initiation step of peptide elongation. Due to the spread of
vancomycin resistance, and the limited use and harsh side effects of linezolid,
daptomycin is an alternative choice for treating Gram-positive infections. Studies have
reported that daptomycin inserts into the cytoplasmic membrane, oligomerizes forming
a pore that leads to membrane depolarization. However, other studies have noted
additional possible outcomes upon drug treatment, suggesting that the mechanism of
killing may have multiple layers. Work with Bacillus subtilis noted that daptomycin
localizes to areas of higher membrane fluidity, possibly effecting the localization of cell
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membrane and cell wall synthesis machinery. Upregulation of the dlt operon,
responsible for adding positively charged residues to wall teichoic acids, in
Staphylococcus aureus has been shown to increase resistance to daptomycin [4].
Interestingly, a thicker cell wall in S. aureus also increases resistance to daptomycin [5].
Disruption of multiple pathways may be the reason the mechanism of killing for
daptomycin is so difficult to understand.
Daptomycin resistance has been reported in a variety of clinical species. An
invaluable resource for understanding drug activity and resistance specifically in E.
faecalis has been a daptomycin resistant clinical isolate pair obtained before and after
antibiotic treatment. Comparing genomic sequences of the pair revealed mutations in
the genes in cardiolipin synthase 1(cls), glycerophosphoryl diester phosphodiesterase
(gdpD) and lipid II interacting antibiotic component (liaF) in the resistant isolate, all of
which are believed to influence cell membrane phospholipid composition. The major
contributor to resistance, however, was determined to be the mutation in the liaF gene.
LiaF represses signaling via the LiaS sensor to the response regulator LiaR which in
turn activates expression of the liaHIGFSR operon; thus, mutation in liaF results in
heighten expression of the liaHIGFSR. After transcriptional upregulation, LiaI and LiaH
localize to the membrane preventing damage by an unknown mechanism [6-8].
Cardiolipin synthase (cls1) is responsible for making the phospholipid cardiolipin,
unique in that it is composed of a single glycerophosphate head and four acyl chain
tails. This shape likely has a specific function in cell curvature due to its narrow head
and wide tail region. Having four acyl tails to a single glycerophosphate head also
decreases the overall charge further than that of its precursor, phosphatidylglycerol.
Cardiolipin has been noted to localize to cell poles and septa in E. faecalis, both being
regions of high cell membrane curvature. The essential membrane division protein
DivIVA localizes to regions of high membrane curvature likely due the strong negative
charge from cardiolipin. The mutation observed in cls1 is thought to increase the
function and subsequently the proportion of cardiolipin in the membrane. GdpD is
responsible for the production glycerol-3-phosphate (G3P) by recycling
glycerophosphodiesters of varying structure [9]. Mutation in gdpD alone does not
increase the minimal inhibitory concentration (MIC) of E. faecalis to daptomycin, but it is
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synergistic with gain of function mutation in cls1. These genes represent the known
mechanisms of genetic resistance, but E. faecalis also shows tolerance to daptomycin
in certain environments rich in mammal associated fatty acids.
Work by Saito and colleagues [10, 11] showed that growing E. faecalis in host
fatty acids drastically increased survival after challenge with daptomycin. Further, only
unsaturated fatty acids oleic acid and linoleic acid present in serum or bile induced
protection. Work by Harp and colleagues [12] demonstrated that this tolerance induction
by oleic or linoleic acids occurs independently of liaR, indicative that the protective fatty
acids are not turning on this signaling pathway. Further work by Harp and colleagues
also showed that the fatty acid induction of tolerance occurred independently of the
known cardiolipin synthase genes (both cls1 and cls2), identifying this as a unique
mechanism not based on known genetic resistance mechanisms (Harp, Unpublished).
We hypothesize that oleic acid induces a unique transcriptional response that leads to
daptomycin tolerance. Within, we use RNA-Seq to examine changes in the
transcriptome of E. faecalis OG1RF in response to exposure to the daptomycin-tolerant
inducing fatty acid oleic acid as well as several control fatty acids.

Materials and Methods
Growth conditions. E. faecalis OG1RF was grown statically at 37°C in brain heart
infusion (BHI) for all experimental conditions. Overnight cultures were diluted to OD 600nm
0.01 before experimentation. When cultures reached OD600nm 0.25, cultures were split
into 50 ml aliquots, leaving a no supplemented control, and supplemented with a solvent
control (ethanol 0.2%) and fatty acids of the following concentrations: cis-vaccenic acid
(C18:1 cis11)(20 g ml-1), oleic acid (C18:1 cis9)(20 g ml-1, 70.8), stearic acid (C18)(10 g ml1),

and oleyl sulfate (C18:1 cis9 SO4)(20 gml-1). After 15 minutes of incubation, cells were

spun down at 2,739g, washed with 1x PBS twice, pelleted and stored at -80°C for RNA
extraction.
RNA extraction. RNA was extracted using the hot phenol: chloroform extraction
method described previously [13]. RNA was treated with DNase and the final chloroform
extraction step was repeated. 3M sodium acetate and 99% were added to the
supernatant, followed by ethanol precipitation. RNA pellet was hydrated with RNase
free water.
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RNA Sequencing. After RNA quality was confirmed via agarose gel and analysis on a
Bioanalyzer (give product name/number), ribosomal RNA was reduced using a
Ribominus transcriptome isolation kit for yeast and bacteria (Invitrogen). Complimentary
DNA (cDNA) library was prepared using the TruSeq stranded mRNA sample kit
(Illumina). cDNA was run on a Miseq V3 150 flow cell lane, producing paired end 75
base pair reads. cDNA library prep, RNA removal, and Miseq was performed by the
Genomics Core at the University of Tennessee Knoxville,
Read analysis. Reads were trimmed using Trimmomatic [14] with a PHRED score
cutoff of 34 and a length minimum of 55 base pairs. Reads below these limits were
dropped from the pool of eligible reads. After trimming, eligible reads were mapped to
the OG1RF reference genome (NC_017316.1) using STAR [15] and the reference
genome annotation (ASM17257v2.46) from Ensemble genomes. Uniquely mapped
reads were counted using HTSeq [16]. Counts were exported to Rstudio (Rstudio,
2015) for differential expression analysis using EdgeR. Differentially expressed genes
were determined using a false discovery rate cutoff of 0.05. All figures comparing
differentially expressed genes were constructed using Rstudio. Housekeeping gene
counts were exported from count files for analysis. The average TPM (Transcripts Per
Kilobase Million) and standard deviation across all conditions was calculated for each of
the shown housekeeping genes.

Results
RNA isolation from cells treated with protective and non-protective fatty acids.
Previously, we noted that when OG1RF is pre-grown in either bile or serum, the cells
are protected from high concentrations of daptomycin. This protective response was
further elucidated to be due to the presence of either oleic acid (C18:1cis9) or linoleic acid
(C18:2cis9,12). Interestingly, supplementation with fatty acids of similar length of
unsaturation did not induce protection: addition of either stearic acid (C18), which is also
found in bile or serum and natively in the membrane of OG1RF, or cis-vaccenic acid
(C18:1cis11) which is one of the major, native fatty acids found in the membrane of
OG1RF, did not. Additional work using oleyl sulfate (C18:1 cis9 SO4), an analog of oleic
acid having a sulfate group instead of a carboxylic group, revealed that it could also
induce protection from daptomycin. However, tolerance induction by these fatty acids
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occurred independently of the liaFSR signaling cascade which is critical for genetic
resistance to daptomycin.
As protective fatty acids could be inducing signaling pathways and other gene
expression changes in OG1RF, we performed a global transcriptome analysis. Cells
were grown to exponential phase in BHI (Brain heart infusion) media, then divided and
either received no addition, solvent control, oleic acid (protective; C18:1cis9), cis-vaccenic
acid (non-protective, C18:1cis11), stearic acid (non-protective, C18:0), or oleyl sulfate
(protective, C18:1SO4cis9) for 15 minutes to capture primary transcriptional responses.
Sequencing of cDNA resulted in 150 million reads, 39 million of those mapping uniquely
to the OG1RF genome. This gave a depth of coverage of 14.2, lower than desired, but
unavoidable considering poor efficiency of the ribosomal RNA removal. All runs
contained high quality reads, averaging around PHRED score of 35. Trimming removed
a small portion (<1%) of reads based on quality and length.
Transcription is consistent across conditions.
To validate the consistency of our treatment groups, we examined whether select
housekeeping genes varied among the biological replicates across a treatment group.
These genes were selected based on roles in essential processes. Genes selected
include DNA gyrase subunit A (OG1RF_RS00040, gyrA), serine
hydroxymethyltransferase (OG1RF_RS09890, glyA), penicillin binding protein
(OG1RF_RS03750, PBP), Div1B cell division protein (OG1RF_RS03770, div1B), and α/β
hydrolase (OG1RF_RS00480). Examining the average TPM (transcripts per kilobase
million) (Figure 1) across conditions verifies that differentially expressed genes are
targeted and not an overall change to the transcriptome.
Basal transcriptional changes in solvent control cells.
As our fatty acid supplements are reconstituted in ethanol, we included a solvent control
to rule out the effects of ethanol on transcriptional changes. We observed a small, but
significant group of transcripts altered when cells were given ethanol versus those cells
with no addition (Figure 3.1). Interestingly, OG1RF_RS05020, one of four homologs of
fakB in Staphylococcus aureus responsible for binding exogenous fatty acids for later
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Figure 3.1: Housekeeping gene expression across fatty acid conditions.
Average Log TPM of housekeeping genes after exposure to a fatty acid supplement for
15 minutes. Expression is stable across conditions, indicating the validity differentially
expressed genes.
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use in lipid synthesis, was reduced in ethanol compared to no supplement addition. The
fakB homolog was also reduced in all fatty acid conditions except stearic acid.
Unsaturated fatty acid supplementation has an impact on transcription.
Of the supplemented fatty acids, both the readily incorporated [10, 11] cis-vaccenic acid
and oleic acid caused a varied response to the transcriptome of OG1RF. We noted
genes associate with metal transport, clpB involved in general stress response, and
interestingly glycerophosphoryl diester phosphodiesterase (gdpD) were all upregulated
in oleic acid supplemented cells (Table 3.1). A gene of interest, clpB has been shown to
act as part of the stress response across bacterial species, degrading aggregates of
non-functional proteins. In Bacillus species, gdpD is responsible for the generation of
glycerol-3-phosphate using a variety of substrates, including wall macromolecules in
Bacillus pumilus [6]. Deletion of the glycerophosphoryl diester phosphodiesterase yqiK
in B. subtilis renders the cell susceptible to high saline stress, implying a role in
osmoprotection [6]. Upregulation of this gene is of particular note due to its role in
genetic resistance to daptomycin in the E. faecalis clinical strain mentioned above.
Unfortunately, our analysis revealed no differentially expressed genes between oleic
acid and cis-vaccenic acid. Instead, comparison of genes found in supplements against
solvent control (Table 3.1) were used to find the upregulation of OG1RF_RS05275,
uniquely regulated in oleic acid supplemented cells. This gene encodes a glycoside
hydrolase family 1 protein, necessary for the cleavage of bonds between carbohydrates.
Research has primarily been focused on cellulose metabolism, but it has been reported
that substrate specificity for protein members of this is low [17].
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Table 3.1 Differentially expressed (DE) genes of O1RF in fatty acid supplements
compared to solvent control. Left column contains gene names. Middle column contains
the Log2 fold change (LogFC) of the gene relative to solvent control cells. Right column
contains false discovery rate P-value (FDR) as determined by the EdgeR differential
expression analysis R package.
A. DE genes of cells supplemented with BHI compared to solvent control cells
BHI DE genes

logFC

FDR

OG1RF_RS05020

DegV family protein

4.27

0.0096

OG1RF_RS08730

type I glutamate--ammonia ligase

2.53

0.017

OG1RF_RS05015

DUF1836 domain-containing protein

3.94

0.039

B. DE genes of oleic acid supplemented cells compared to solvent control.
Oleic acid DE genes

logFC

FDR

OG1RF_RS01350

copper-translocating P-type ATPase

4.51

0.00078

OG1RF_RS05915

magnesium-translocating P-type ATPase

2.81

0.0016

OG1RF_RS03080

YhgE/Pip domain-containing protein

3.4

0.0016

OG1RF_RS06160

cadmium-translocating P-type ATPase

5.89

0.0021

OG1RF_RS01345

CopY/TcrY family copper transport repressor

4.16

0.0021

OG1RF_RS02615

MgtC/SapB family protein

6.41

0.0025

OG1RF_RS02700

glycerophosphoryl diester phosphodiesterase

2.58

0.013

OG1RF_RS09175

ATP-dependent chaperone ClpB

2.98

0.013

OG1RF_RS02365

ATP-dependent Clp protease ATP-binding

3.6

0.018

subunit
OG1RF_RS02610

heavy metal translocating P-type ATPase

6.2

0.023

OG1RF_RS05275

glycoside hydrolase family 1 protein

1.35

0.026

OG1RF_RS02705

NUDIX hydrolase

2.46

0.026

OG1RF_RS01355

heavy-metal-associated domain-containing

3.45

0.035

protein
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Table 3.1 continued
C. DE genes of cis-vaccenic acid supplemented cells compared to solvent control.
Cis-vaccenic DE genes

logFC

FDR

OG1RF_RS01350

copper-translocating P-type ATPase

3.88

0.0068

OG1RF_RS06160

cadmium-translocating P-type ATPase

5.75

0.0068

OG1RF_RS02700

glycerophosphoryl diester phosphodiesterase

2.82

0.0068

OG1RF_RS02615

MgtC/SapB family protein

5.96

0.011

OG1RF_RS05915

magnesium-translocating P-type ATPase

2.319

0.026

OG1RF_RS03080

YhgE/Pip domain-containing protein

2.80

0.026

OG1RF_RS02705

NUDIX hydrolase

2.50

0.026

OG1RF_RS02365

ATP-dependent Clp protease ATP-binding

3.60

0.026

subunit
OG1RF_RS01345

CopY/TcrY family copper transport repressor

3.41

0.026

OG1RF_RS00125

hypothetical

3.28

0.026

OG1RF_RS04400

universal stress protein

2.19

0.026

OG1RF_RS03430

UvrD-helicase domain-containing protein

2.43

0.030

OG1RF_RS02610

heavy metal translocating P-type ATPase

5.91

0.034

OG1RF_RS09175

ATP-dependent chaperone ClpB

2.67

0.037

OG1RF_RS06755

GNAT family N-acetyltransferase

2.40

0.048

D. DE genes of stearic acid supplemented cells compared to solvent control.
Stearic acid DE genes
OG1RF_RS05020

DegV family protein

logFC

FDR

3.91

0.043
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Discussion
To better understand the consequences of fatty acid supplementation upon E. faecalis
and their possible contributions to daptomycin tolerance, E. faecalis was supplemented
with different fatty acids, all 18 carbons in length, that differed in their abilities to induce
tolerance. To rule out variation across replicates, we employed a similar strategy used
by Martin [18] by comparing reads of the same housekeeping genes across conditions
to ensure valid detection of differentially expressed genes. We do note that the solvent
control did impact gene expression compared to media control; however, we compared
gene expression of our fatty acid supplements to the solvent to better determine unique
effects from the fatty acids.
When compared to the solvent control, we found that supplementation with
unsaturated fatty acids induced upregulation of genes associated with stress response,
likely due to the unsaturated fatty acid dominated membrane having altered
physiological properties. Also noted was the upregulation of genes for metal transport,
similar to OG1RF treated with ampicillin, bacitracin, cephalosporin, or vancomycin.
Given the wide range of stresses caused by fatty acid supplementation and the
mentioned antibiotics, metal transport maybe part of general stress response in E.
faecalis in response to cell envelope alterations [19]. Another gene upregulated in both
unsaturated fatty acids encodes for a NUDIX hydrolase. Recent work has shown that
Mycobacterium smegmatis uses specific NUDIX hydrolases to control the amount of
acyl-CoA in the cell, diverting the chains towards ADP synthesis. While NUDIX
hydrolases have been implicated in the inactivation of many molecules, including
mutagenic nucleoside triphosphates, sugar molecules, and signaling molecules, each
hydrolase is specific to its substrate. This specificity necessitates many different NUDIX
hydrolase genes, for example 30 different NUDIX hydrolase genes are observed in
Bacillus anthracis [20]. Understanding the role of NUDIX hydrolase in E. faecalis will
require work specific to the organism and this particular hydrolase.
Given protection is only induced by oleic acid and not the similar fatty acid cisvaccenic acid, it was interesting to find no differentially expressed genes within this
comparison. Oleic acid and cis-vaccenic acid only differ in the placement of the double
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bond, carbon 9 in oleic acid and carbon 11 in cis-vaccenic acid, but this difference is
sufficient to induce protection. Although direct comparison produced no genes of
interest, indirect comparison of differentially expressed genes between oleic acid to
solvent control and cis-vaccenic to solvent control produced one gene that encodes for
a glycoside hydrolase family 1 protein. Mostly researched for the industrial production of
glucose from cellulose, members of this protein family are not very specific and can use
different carbohydrates as substrate [17]. However, no work, that we are aware of, in E.
faecalis indicates its possible contribution to protection from daptomycin.
Apart from known functions in producing G3P, a homolog of GdpD in Bacillus
subtilis (YqiK) was demonstrated to protect from high salt concentrations by regulating
wall structure to avoid excess turgor pressure. Another homolog in Bacillus pumilus was
demonstrated to use wall components such as teichoic acids as a substrate,
presumably changing the structure of the wall. Further, work with Staphylococcus
aureus demonstrated a homolog of GdpdD is required for resistance to β-lactam
antibiotics [9]. Given that mutation in gdpD alone is not sufficient to increase MIC of
daptomycin in E. faecalis [21], it is likely that fatty acid induced protection also requires
more than just increased transcription of gdpD. Previous work in other organisms has
shown that glycoside hydrolase family 1 proteins break down cellulose into glucose
monomers, mainly useful for metabolism of carbohydrates. As there are published
findings supportive that daptomycin maybe targeting features of the cell wall, and not
just the cell membrane, it is possible that wall modification by glycoside hydrolase family
1 protein, in conjunction with wall modification by GdpD, leads to the observed
daptomycin tolerant phenotype.
Herein we show that exogenous supplementation of E. faecalis with fatty acids
induces changes to transcriptional regulation. While most changes are not unique to the
protective supplement oleic acid, upregulation in gdpD and a gene encoding for
glycoside hydrolase family 1 protein are a promising future avenue of research into the
mechanism of fatty acid induced tolerance to daptomycin.
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A.

Figure 3.2: Log2 fold change of genes between fatty acid supplements and
solvent control. MA plot of differentially expressed genes between supplemented
conditions; (A) Ethanol vs BHI (B) Ethanol vs Oleic acid (C) Ethanol vs Cis-vaccenic
acid (D) Ethanol vs Stearic acid (E) Ethanol vs Oleyl sulfate. Cutoff for significance is a
log fold change of 2 and an FDR of 0.05. Significant genes are shown as red dots.
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B.

Figure 3.2 continued
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C.

Figure 3.2 continued
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D.

Figure 3.2 continued
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E.

Figure 3.2 continued
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Chapter 4: Conclusions
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Past work by members of the lab revealed the Enterococcus faecalis can take fatty
acids from host fluids to gain tolerance to daptomycin. Further studies noted that each
fatty acid present in host fluids causes a different effect to the cell, with only the
unsaturated fatty acids oleic acid (C18:1cis9) and linoleic acid (C18:2cis9,12) inducing
tolerance [1, 2]. Further exploration demonstrated that the daptomycin tolerant
phenotype is not associated with the major genetic resistance mechanism [3]. The work
presented in this thesis aims at understanding the impact of fatty acid supplementation
on physiology and transcriptional regulation.
Combination fatty acid supplementation favors protection
Host fluid supplementation induces daptomycin tolerance, yet it is composed of both
protective and non-protective fatty acids. The protective fatty acids oleic acid and
linoleic acid are both 18 carbons in length and unsaturated. Conversely, the nonprotective fatty acids stearic acid (C18) and palmitic acid (C16) are both saturated but
differ in length. While I use protective and non-protective to describe the fatty acids,
there are negative effects on cell physiology associated with the non-protective fatty
acids as well. Linoleic acid causes an increase in generation time when supplemented
at 20 µgml-1 [1, 2]. Both stearic acid and palmitic acid delay growth and induce heavily
disfigured cells, making it all the more curious that host fluids protect while conferring
neither of these negative effects.
In order to understand the interplay between protective and non-protective fatty
acids, I performed a series of physiological assays after supplementation of E. faecalis
with combinations (protective and non-protective) of fatty acids. Cell growth,
morphology, membrane fluidity, cerulenin rescue, and daptomycin protection induced by
fatty acid combinations all followed trends for the protective fatty acid in the mixture. Our
combining all four fatty acids to create a “synthetic serum” matched human serum in
daptomycin protection, further supporting that fatty acids contained in host fluids are
solely responsible for tolerance. While the mechanism is still unclear, we have shown
that the presence of a protective fatty acid will protect from daptomycin and the negative
physiological effects caused by non-protective fatty acids.
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Membrane fluidity as a target for daptomycin
Research with Bacillus subtilis has looked into membrane fluidity, noticing daptomycin
preferentially binding to fluid microdomains, which leads to decreased fluidity and
delocalization of membrane bound cell wall machinery [4]. Our numerous accounts of
only specific unsaturated fatty acids inducing daptomycin tolerance indicated that
protection is not as simple as increasing membrane fluidity. Previous GC-FAME (gas
chromatography fatty acid methyl ester) data showed that cis-vaccenic and oleic acid
makes up as much as 70% of the membrane fatty acid tails when supplemented as the
sole fatty acid from inoculation [1]. Similarly, anisotropy shows that cis-vaccenic makes
the membrane just as fluid as oleic acid when supplemented for 30 minutes during midlog growth (Fig 4.1), and yet, only oleic acid can induce protection under these
conditions [2]. A pilot experiment indicates that daptomycin in fact increases membrane
fluidity of E. faecalis (Fig 4.2). Note that this measurement is done as a bulk
measurement of cells, and that the concentration of daptomycin used was a minimum of
15 µgml-1 (MIC 2-4 ug/ml normally for this strain). This is unlike the above-mentioned B.
subtilis study which relied on lower concentration of daptomycin and fluorescent
microscopy using dyes to examine localized regions. Further, the membrane
phospholipid and fatty acid composition of B. sub and E. faecalis are different, which
could give contradictory results. Regardless, our combined data comparing cis-vaccenic
and oleic acid across multiple physiological assays does not seem to support a role for
membrane fluidity as controlling/inducing tolerance to daptomycin.
Cell wall as a target for daptomycin
While performing membrane anisotropy, we were concerned about the cell wall possibly
interfering with access to the membrane by DPH. Consequently, we generated
protoplasts. We also noted that several studies have implied cell wall alterations as a
driver for daptomycin protection/resistance. Alterations to cell wall include adding
positive charge via the dlt operon and thickening of the cell wall in Bacillus subtilis, as
well as cell wall homeostasis proteins in Staphylococcus aureus and Enterococcus
faecium [5]. We decided then to test the susceptibility of protoplasts to daptomycin with
and without pre-growth protective fatty acid supplementation. Surprisingly, we observed
dramatic protection from daptomycin from the protoplasts as opposed to whole cells
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(Fig 4.3). Cell wall removal increased survival just as much as oleic acid
supplementation did for the whole cells. However, in comparing whole cells versus
protoplasts formed from cultures pre-grown in oleic acid, there was little to no change in
survival of protoplasts.
Fatty acid supplementation alters transcription
After ruling out connections to all known daptomycin genetic resistance mechanisms,
we designed an experiment to discover genes associated with tolerance. We used an
assortment of fatty acid supplements meant to be similar in form, but different in the
effect on cellular physiology, as well as appropriate media and solvent controls. Oleic
acid was used as the target for genes of interests. Cis-vaccenic is the same length as
oleic acid but differs in the location of the double bond and does not induce daptomycin
protection. Oleyl sulfate has the same acyl tail as oleic acid but has a sulfate head
group instead of a carboxylic head group, theoretically unable to be incorporated onto a
phospholipid head group. Interestingly, even though it cannot be incorporated onto a
head group, it is still able to protect from daptomycin: transcriptional changes that
overlap with oleyl sulfate and oleic acid, but not with others, could be strong candidates
for protective responses. Stearic acid is the same length as oleic acid but is saturated
and does not induce protection.
Typically, hypotheses attempting to explain daptomycin mechanism of killing
involves the cell membrane, either by creating discrete pores or ion leakage [6]. These
proposed mechanisms also relate cell charge and increased proportions of lysylphosphatidylglycerol (lysyl-PG) to protection, assuming that daptomycin operates via
charge affinity with negatively charge regions of the membrane, but our data suggests
no correlation of charge or lysyl-PG levels with daptomycin susceptibility [6] (Harp, in
preparation) (chapter 2).
Using solvent control as a baseline for comparison, transcriptomic analysis
revealed the upregulation of a gene encoding glycoside hydrolase family 1 protein only
when supplemented with oleic acid. Glycoside hydrolase breaks glycosylic bonds
between sugar monomers in a carbohydrate, usually studied in respect to glucose
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Figure 4.1: Membrane fluidity of OG1RF supplemented with unsaturated C18 fatty
acids. DPH fluorescence anisotropy of OG1RF after long term supplementation with
0.2% ethanol, 20 µgml-1 oleic acid, or 20 µgml-1 cis-vaccenic acid. Higher r value
indicates a more ordered and less fluid cell membrane. Asterisk indicates difference
between indicated condition and solvent control (ethanol) with a P value below 0.05.
n=3

70

Figure 4.2: Membrane fluidity of OG1RF after daptomycin challenge. DPH
fluorescent anisotropy of OG1RF supplemented with 0.2% ethanol or 5 µgml -1 of
indicated fatty acid(s) for 30 minutes before challenge with indicated concentration of
daptomycin. Higher r value indicates a more ordered and less fluid cell membrane. n=1.
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Figure 4.3: Daptomycin challenge of protoplast and whole cell OG1RF. 30 µgml-1
Daptomycin challenge of whole cells and protoplasts supplemented with 0.2% ethanol
and 20 µg ml-1 oleic acid.
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production from cellulose [7]. This protein becomes more interesting if the true target (or
one of the targets) of daptomycin is the cell envelope. Another gene of note upregulated
in oleic acid supplemented cells was glycerophosphoryl diester phosphodiesterase
(gdpD), upregulated in both cis-vaccenic acid and oleic acid relative to solvent control.
GdpD is a known daptomycin resistance gene and responsible for glycerol-3-phosphate
production, but having off target, wall modification effects in Bacillus pumilus [8, 9].
Although found mutated in a daptomycin resistant enterococcal strain, when the
mutation was generated alone, there was no effect on MIC to daptomycin but instead,
appears to have a synergistic effect with other daptomycin resistant mutations [8]. If we
expand the possibilities of daptomycin targeting to the cell wall, then upregulation in
both gdpD and glycoside hydrolase could lead to wall modification, making both genes
relevant to daptomycin tolerance. Upregulation of gdpD seen in cis-vaccenic
supplemented cells may not be sufficient for protection, but the combination of
upregulation in both gdpD and glycoside hydrolase in oleic acid supplemented cells may
mirror the reliance of gdpD on another gene to protect from daptomycin in the
daptomycin resistant clinical isolate. Further work is required to validate this hypothesis.
Future directions
We have shown that protective fatty acids are able to negate any deleterious effects
from non-protective fatty acids while protecting from daptomycin but have only been
able to rule out mechanisms. Transcriptomic analysis reveals an interesting avenue of
research, possibly connecting the genetic resistance gene gdpD with the oleic acid
induced upregulation of glycoside hydrolase. Creating a mutant lacking gdpD and
glycoside hydrolase would confirm our suspicions that these genes are vital to the
protection seen by oleic acid supplemented cells. Because we know gdpD upregulation
alone is not sufficient to induce protection from daptomycin, we should start with a
glycoside hydrolase mutant. Then in the same construct lacking a functional glycoside
hydrolase, we also inactivate gdpD. The purpose is to elucidate the interplay between
glycoside hydrolase and gdpD. If the glycoside hydrolase mutant alone loses protection
from daptomycin then we know gdpD is not necessary, however the upregulation of
both genes in oleic acid supplemented cells implies both are necessary for daptomycin
protection.
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In conjunction with molecular verification of cell wall remodeling, the survival of
protoplasts after daptomycin challenge could also provide evidence of cell wall
modification being responsible for daptomycin tolerance. It is likely that gently removing
the cell wall while generating protoplasts also removes an essential target of
daptomycin. We know by Gram staining that the cell wall is gone in protoplasts, so the
activity of GdpD and glycoside hydrolase may selectively remove a target of daptomycin
in a way that keeps the cell wall intact and viable. Daptomycin challenge assays will
continue to be a hallmark of this project as the focus narrows to the effector rather than
the causative agent, as seen in my work.
If the previously mentioned future experiments fail to identify the cause of
daptomycin tolerance, we could investigate the cell wall of E. faecalis. Cell wall is clearly
important to the mechanism of killing by daptomycin. Given this recent revelation, we
should characterize the carbohydrate composition of the cell wall when grown in
different fatty acid supplements. Assuming that the cell wall is being remodeled in the
presence of protective fatty acids, it stands to reason there will be an observable
change in the carbohydrate composition.
Lastly, we have recently sent out samples to a collaborator in order to quantify
the lipid species composition of cell membranes after supplementation with fatty acid
combinations using mass spectroscopy. Fatty acid composition analysis by GC-FAME
of cell membranes supplemented with multiple fatty acids show that in most instances,
both protective and non-protective fatty acids are in the membrane. The reason we
have used mass spectroscopy in the past and continue to use it is because we can tell if
the fatty acid we are detecting is incorporated onto the membrane as a phospholipid or
floating free as an acyl chain. Comparing the GC-FAME lipid composition with mass
spectroscopy analysis should provide evidence supporting or refuting the hypothesis
that it matters for daptomycin protection that the supplemented protective fatty acid is
present as a free fatty acid or incorporated onto a phospholipid.
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